GlobalData on MSN11d
MSD reports topline outcomes from Phase III NSCLC trial of pembrolizumab
MSD has reported positive topline outcomes from the Phase III study of subcutaneous pembrolizumab in conjunction with ...
Eupraxia presents new PK data from its Phase 2a Eosinophilic Esophagitis program
Eupraxia Pharmaceuticals (EPRX)unveiled new pharmacokinetic, or PK data from its Phase 2a Eosinophilic Esophagitis, or EoE, program.
EXCLUSIVE: Adial Pharmaceuticals Reveals Topline Results From Pharmacokinetics Study Of AD04 For Alcohol Use Disorder
Thursday, Adial Pharmaceuticals Inc (NASDAQ:ADIL) said it has completed a pharmacokinetics (PK) study of AD04 for Alcohol Use ...